Dedifferentiated Solitary Fibrous Tumor: A Concise Review

Arch Pathol Lab Med. 2018 Jun;142(6):761-766. doi: 10.5858/arpa.2016-0570-RS.

Abstract

Solitary fibrous tumor (SFT) is a unique mesenchymal neoplasm that was originally believed to be of submesothelial origin. Eventually, SFT expanded to include what was previously called hemangiopericytoma in other regions of the body that had similar immunohistochemical and morphologic features. Although most are benign, many studies have tried to identify histologic features that predict which tumors will behave in an aggressive manner. Recently, dedifferentiation has been described in rare cases of SFT and does appear to correlate with a more aggressive clinical course. Dedifferentiated SFT occurs in a similar age range and location as conventional SFT and can resemble multiple different malignant entities. Utilization of ancillary studies and thorough tissue sampling is important to reach the correct diagnosis. The morphologic features, immunohistochemistry, molecular alterations, and prognosis will be discussed.

Publication types

  • Review

MeSH terms

  • Cell Dedifferentiation
  • Hemangiopericytoma / diagnosis
  • Hemangiopericytoma / genetics
  • Hemangiopericytoma / pathology*
  • Humans
  • Immunohistochemistry
  • Prognosis
  • Solitary Fibrous Tumors / diagnosis
  • Solitary Fibrous Tumors / genetics
  • Solitary Fibrous Tumors / pathology*